These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 7838530
1. Interaction between p53 and TGF beta 1 in control of epithelial cell proliferation. Blaydes JP, Schlumberger M, Wynford-Thomas D, Wyllie FS. Oncogene; 1995 Jan 19; 10(2):307-17. PubMed ID: 7838530 [Abstract] [Full Text] [Related]
2. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype. Coppa A, Mincione G, Lazzereschi D, Ranieri A, Turco A, Lucignano B, Scarpa S, Ragano-Caracciolo M, Colletta G. J Cell Physiol; 1997 Aug 19; 172(2):200-8. PubMed ID: 9258341 [Abstract] [Full Text] [Related]
3. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1. Williams AC, Browne SJ, Manning AM, Daffada P, Collard TJ, Paraskeva C. Oncogene; 1994 May 19; 9(5):1479-85. PubMed ID: 8152811 [Abstract] [Full Text] [Related]
4. Loss of growth control by TGF-beta occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation. Haddow S, Fowlis DJ, Parkinson K, Akhurst RJ, Balmain A. Oncogene; 1991 Aug 19; 6(8):1465-70. PubMed ID: 1886717 [Abstract] [Full Text] [Related]
5. TGF beta regulation of epithelial cell proliferation: role of tumor suppressor genes. Moses HL, Pietenpol JA, Münger K, Murphy CS, Yang EY. Princess Takamatsu Symp; 1991 Aug 19; 22():183-95. PubMed ID: 1844240 [Abstract] [Full Text] [Related]
6. Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events. Malliri A, Yeudall WA, Nikolic M, Crouch DH, Parkinson EK, Ozanne B. Cell Growth Differ; 1996 Oct 19; 7(10):1291-304. PubMed ID: 8891333 [Abstract] [Full Text] [Related]
7. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells. Zhao J, Buick RN. Cancer Res; 1995 Dec 15; 55(24):6181-8. PubMed ID: 8521411 [Abstract] [Full Text] [Related]
8. The capacity for growth stimulation by TGF beta 1 seen only in advanced colon cancers cannot be ascribed to mutations in APC, DCC, p53 or ras. Huang F, Hsu S, Yan Z, Winawer S, Friedman E. Oncogene; 1994 Dec 15; 9(12):3701-6. PubMed ID: 7970729 [Abstract] [Full Text] [Related]
9. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells. Guo Y, Kyprianou N. Cell Growth Differ; 1998 Feb 15; 9(2):185-93. PubMed ID: 9486855 [Abstract] [Full Text] [Related]
10. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta. Manning AM, Williams AC, Game SM, Paraskeva C. Oncogene; 1991 Aug 15; 6(8):1471-6. PubMed ID: 1886718 [Abstract] [Full Text] [Related]
11. Evasion of p53-mediated growth control occurs by three alternative mechanisms in transformed thyroid epithelial cells. Wyllie FS, Haughton MF, Blaydes JP, Schlumberger M, Wynford-Thomas D. Oncogene; 1995 Jan 05; 10(1):49-59. PubMed ID: 7529918 [Abstract] [Full Text] [Related]
12. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells. Tang B, de Castro K, Barnes HE, Parks WT, Stewart L, Böttinger EP, Danielpour D, Wakefield LM. Cancer Res; 1999 Oct 01; 59(19):4834-42. PubMed ID: 10519393 [Abstract] [Full Text] [Related]
13. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Grau AM, Zhang L, Wang W, Ruan S, Evans DB, Abbruzzese JL, Zhang W, Chiao PJ. Cancer Res; 1997 Sep 15; 57(18):3929-34. PubMed ID: 9307274 [Abstract] [Full Text] [Related]
14. The tumor suppressor gene p53 can mediate transforming growth [corrected] factor beta1-induced differentiation of leukemic cells independently of activation of the retinoblastoma protein. Ehinger M, Bergh G, Johnsson E, Gullberg U, Olsson I. Cell Growth Differ; 1997 Oct 15; 8(10):1127-37. PubMed ID: 9342191 [Abstract] [Full Text] [Related]
15. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells. Moretti F, Farsetti A, Soddu S, Misiti S, Crescenzi M, Filetti S, Andreoli M, Sacchi A, Pontecorvi A. Oncogene; 1997 Feb 13; 14(6):729-40. PubMed ID: 9038381 [Abstract] [Full Text] [Related]
18. Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation. Montano X. Oncogene; 2009 Oct 29; 28(43):3787-800. PubMed ID: 19749791 [Abstract] [Full Text] [Related]
19. [The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells]. Kremenetskaia OS, Logacheva NP, Baryshnikov AIu, Chumakov PM, Kopnin BP. Tsitologiia; 1996 Oct 29; 38(12):1280-93. PubMed ID: 9163103 [Abstract] [Full Text] [Related]
20. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2. Joyce NC, Harris DL, Mello DM. Invest Ophthalmol Vis Sci; 2002 Jul 29; 43(7):2152-9. PubMed ID: 12091410 [Abstract] [Full Text] [Related] Page: [Next] [New Search]